📰 Rna Interference News
Rna Interference News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rna Interference. Real-time updates on events, politics, business and more.
May 1, 2024
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The
January 22, 2024
Researchers explored how Death Induced by Survival gene Elimination through the analysis of RNA-induced silencing complex-bound short RNAs in Alzheimer's disease models influences neuronal survival and correlates with neurotoxicity in AD.
January 18, 2024
Alzheimer's disease, which is expected to have affected about 6.7 million patients in the U.S. in 2023, results in a substantial loss of brain cells.
January 10, 2024
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The
January 9, 2024
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CFO Kenneth Myszkowski sold 16,104 shares of the company's stock on January 5, 2024, according to a SEC Filing.
January 3, 2024
SOUTH SAN FRANCISCO, Calif., January 03, 2024--Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D., as Chief Technology Officer (CTO).
November 15, 2023
The global RNA therapeutics market is driven by the increasing number of government initiatives for large-scale sequencing projects, target specificity, and selectivity of treatment.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “RNA Based Therapeutics Market by Disease Type (RNA antisense and RNA interference (RNAi)), Application (Auto-Immune Disorders and Genetic Disorders) and End User (Hospitals & Clinics and Research In...
October 16, 2023
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- In an astounding revelation, scientists at Stockholm University have achieved a first-of-its-kind feat by...
September 21, 2023
On September 18, 2023, Christopher Anzalone, the CEO of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 57,755 shares of the company.